(“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today announced the pricing of its ...

Retension Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. The Company’s lead clinical ...

The Bella Lift places incisions within the hairline, the natural eyelid crease and the inside of the lower eyelid, and most patients return to work within about two weeks. Candidacy, recovery and ...

NDA and MAA of deucrictibant IR for the on-demand treatment of HAE attacks under review by regulatory authorities ZUG, Switzerland, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a ...

Each year, CMS assigns Star ratings to Medicare Advantage and Part D contracts on its healthcare quality and drug plan, and issues a Star rating on a scale of 1 to 5 Stars. These ratings affect ...

This is the longest documented clinical patency, or continuous blood flow, reported to date for a Vascudyne tissue-engineered vessel. Further, Vascudyne has recently completed enrollment in its ...

A growing body of real-world evidence for daridorexant Two poster presentations will provide complementary perspectives from routine clinical practice, examining outcomes across the 24-hour burden of ...

Clue, the #1 women-led period and cycle tracking app, today announced Get Care, marking the first time a mass-market cycle-tracking platform has connected users directly to care across numerous areas ...

The Annual General Meeting of ChemoMetec A/S was held on 8 October 2026 at 17:30 at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of Directors' report on the company's ...

Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the “Placement Agent”), as well as a ...